Related Experiment Video
Updated: Jun 10, 2025

09:36
Open-Source Miniature Fluorimeter to Monitor Real-Time Isothermal Nucleic Acid Amplification Reactions in Resource-Limited Settings
Published on: February 3, 2021
4.8K
Development of a Polymersome Blood Ammonia Assay Coupled with a Portable Near-Infrared Fluorometer
Marie-Lynn Al-Hawat1, Justine Caron1, Sarah Djebbar1
1Faculté de Pharmacie, Université de Montréal, Montreal, Quebec H3T 1J4, Canada.
ACS Bio & Med Chem Au
|October 21, 2024
Summary
Researchers developed a novel point-of-care blood ammonia assay using fluorescent polymersomes. This innovative method offers rapid and accurate ammonia detection in whole blood, crucial for diagnosing liver disease.
Area of Science:
- Biomarker detection
- Nanotechnology for diagnostics
- Point-of-care testing
Background:
- Ammonia is a critical biomarker for liver disease.
- Current clinical assays for blood ammonia are not point-of-care.
- A need exists for rapid, accessible ammonia detection methods.
Purpose of the Study:
- To develop a polymersome-based formulation for point-of-care blood ammonia sensing.
- To combine this formulation with a portable fluorometer for a complete assay.
- To validate the assay's performance in fresh whole blood.
Main Methods:
- Developed ammonia-selective polymersomes loaded with a pH-sensitive near-infrared (NIR) fluorescent dye.
- Tested polymersome performance with ammonia-spiked fresh whole blood using a plate reader.
- Validated the assay with a portable fluorometer using ammonia-spiked mouse blood.
Main Results:
- Polymersomes demonstrated high linearity (R² = 0.9948) in sensing ammonia in whole blood within 5 minutes.
- The assay successfully detected ammonia using a portable fluorometer with fresh mouse blood.
- The assay requires only 3 μL of blood for rapid, linear ammonia detection.
Conclusions:
- NIR fluorescent polymersomes enable rapid and linear ammonia sensing in whole blood.
- The developed assay is compatible with a portable fluorometer for point-of-care use.
- This technology shows promise for clinical translation in liver disease diagnostics.

